These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36951788)

  • 1. Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021.
    Cristea V; Ködmön C; Rosales-Klintz S; Pharris A; van der Werf MJ
    Euro Surveill; 2023 Mar; 28(12):. PubMed ID: 36951788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015.
    Ködmön C; van den Boom M; Zucs P; van der Werf MJ
    Euro Surveill; 2017 Nov; 22(47):. PubMed ID: 29183553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?
    Merk H; Ködmön C; van der Werf MJ
    Euro Surveill; 2019 Mar; 24(12):. PubMed ID: 30914077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012.
    van der Werf MJ; Ködmön C; Hollo V; Sandgren A; Zucs P
    Euro Surveill; 2014 Mar; 19(10):. PubMed ID: 24650865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.
    Karo B; Hauer B; Hollo V; van der Werf MJ; Fiebig L; Haas W
    Euro Surveill; 2015; 20(49):. PubMed ID: 26676247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.
    Ködmön C; Hollo V; Huitric E; Amato-Gauci A; Manissero D
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European policies in the management of tuberculosis among migrants.
    D'Ambrosio L; Centis R; Dara M; Solovic I; Sulis G; Zumla A; Migliori GB
    Int J Infect Dis; 2017 Mar; 56():85-89. PubMed ID: 27836793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022.
    Stoycheva K; Cristea V; Ködmön C; Rosales-Klintz S; Zenner D; Vasiliu A; van der Werf M; Lange C
    Euro Surveill; 2024 Mar; 29(12):. PubMed ID: 38516786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of tuberculosis in the EU/EEA in 2010: monitoring the progress towards tuberculosis elimination.
    Sandgren A; Hollo V; Huitric E; Kodmon C
    Euro Surveill; 2012 Mar; 17(12):. PubMed ID: 22490307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes.
    Collin SM; de Vries G; Lönnroth K; Migliori GB; Abubakar I; Anderson SR; Zenner D
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30309977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis in Poland in 2021.
    Korzeniewska-Koseła M; Wesołowski S
    Przegl Epidemiol; 2024 May; 77(4):449-465. PubMed ID: 38783654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in Poland in 2020.
    Korzeniewska-Koseła M; Wesołowski S
    Przegl Epidemiol; 2022; 76(4):528-546. PubMed ID: 37017237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.
    Hollo V; Kotila SM; Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27035746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009.
    Sandgren A; Hollo V; Quinten C; Manissero D
    Euro Surveill; 2011 Mar; 16(12):. PubMed ID: 21457686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tuberculosis treatment outcomes in the European Union and European Economic Area: efforts needed towards optimal case management and control.
    Manissero D; Hollo V; Huitric E; Kodmon C; Amato-Gauci A
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of multidrug-resistant tuberculosis case notifications in Australia (1999-2018).
    Camphor HS; Viney K; Polkinghorne B; Pennington K
    Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis in Poland in 2017.
    Korzeniewska- Koseła M
    Przegl Epidemiol; 2019; 73(2):211-226. PubMed ID: 31385679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015.
    Hollo V; Beauté J; Ködmön C; van der Werf MJ
    Euro Surveill; 2017 Mar; 22(12):. PubMed ID: 28367798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.